Evidence map›Paper›PMID 31746783›Full record

ArticlePhysics in medicine and biology2019

Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT.

Arda Könik, Benjamin Auer, Jan De Beenhouwer, Kesava Kalluri, Navid Zeraatkar, Lars R Furenlid, Michael A King

Open access · greenAbstract readComparative Study
In one paragraph

Article in Physics in medicine and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Optimisation of Q.Clear (BSREM) Reconstruction Parameters forBioengineering (Basel, Switzerland) · 2026
    Article
  2. Article
  3. The Role ofMedical sciences (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Recent advances in voxel-based targeted radionuclide therapy dosimetry.Quantitative imaging in medicine and surgery · 2021
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Arda KönikDepartment of Imaging, Dana Farber Cancer Institute, Boston, MA 02215, United States of America.
Benjamin AuerDepartment of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, United States of America.
Jan De BeenhouwerUniversity of Antwerp, IMEC-Vision Lab, Antwerp, Belgium.
Kesava KalluriDepartment of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, United States of America.
Navid ZeraatkarDepartment of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, United States of America.
Lars R FurenlidUniversity of Arizona, College of Optical Sciences, Tucson, AZ 85719, United States of America.
Michael A KingDepartment of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, United States of America.
University of Massachusetts Chan Medical School · USDana-Farber Cancer Institute · USUniversity of Antwerp · BEUniversity of Arizona · US

Funding

Combined Multi-Pinhole and Fan-Beam Brain SPECTR01EB022092 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KING, MICHAEL A · 2016 to 2019
$1.6M
NIBIB NIH HHS R01 EB022092
6 · The paper itself

Abstract

Multi-pinhole (MPH) collimators are known to provide better trade-off between sensitivity and resolution for preclinical, as well as for smaller regions in clinical SPECT imaging compared to conventional collimators. In addition to this geometric advantage, MPH plates typically offer better stopping power for penetration than the conventional collimators, which is especially relevant for I-123 imaging. The I-123 emits a series of high-energy (>300 keV, ~2.5% abundance) gamma photons in addition to the primary emission (159 keV, 83% abundance). Despite their low abundance, high-energy photons penetrate through a low-energy parallel-hole (LEHR) collimator much more readily than the 159 keV photons, resulting in large downscatter in the photopeak window. In this work, we investigate the primary, scatter, and penetration characteristics of a single pinhole collimator that is commonly used for I-123 thyroid imaging and our two MPH collimators designed for I-123 DaTscan imaging for Parkinson's Disease, in comparison to three different parallel-hole collimators through a series of experiments and Monte Carlo simulations. The simulations of a point source and a digital human phantom with DaTscan activity distribution showed that our MPH collimators provide superior count performance in terms of high primary counts, low penetration, and low scatter counts compared to the parallel-hole and single pinhole collimators. For example, total scatter, multiple scatter, and collimator penetration events for the LEHR were 2.5, 7.6 and 14 times more than that of MPH within the 15% photopeak window. The total scatter fraction for LEHR was 56% where the largest contribution came from the high-energy scatter from the back compartments (31%). For the same energy window, the total scatter for MPH was 21% with only 1% scatter from the back compartments. We therefore anticipate that using MPH collimators, higher quality reconstructions can be obtained in a substantially shorter acquisition time for I-123 DaTscan and thyroid imaging.

Indexed as

HumansIodine RadioisotopesMonte Carlo MethodNortropanesPhantoms, ImagingPhotonsRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonIodine-123Iodine RadioisotopesioflupaneNortropanesRadiopharmaceuticals

Identifiers

PMID31746783
PMCPMC8507420
OpenAlexW2990191960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.